Literature DB >> 9593596

Melatonin mediates two distinct responses in vascular smooth muscle.

S Doolen1, D N Krause, M L Dubocovich, S P Duckles.   

Abstract

The pineal hormone melatonin was found to produce two distinct contractile responses in vascular smooth muscle. In isolated rat caudal artery segments, denuded of endothelium, melatonin (10(-10)-10(-7) M) potentiated phenylephrine-induced contractions in a concentration-dependent manner. At higher melatonin concentrations (10(-7)-10(-5) M), however, the potentiating effect was attenuated. In the presence of the melatonin MT2 receptor antagonist, 4-phenyl-2-acetamidotetraline (4P-ADOT), the attenuated constrictor responses were selectively enhanced. These results are consistent with the hypothesis that melatonin activates two receptor subtypes in vascular smooth muscle; MT2 receptors may induce relaxation, while a second receptor subtype mediates vasoconstriction.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9593596     DOI: 10.1016/s0014-2999(98)00064-8

Source DB:  PubMed          Journal:  Eur J Pharmacol        ISSN: 0014-2999            Impact factor:   4.432


  44 in total

1.  Melatonin MT-1-receptor immunoreactivity in the human eye.

Authors:  P Meyer; M Pache; K U Loeffler; L Brydon; R Jockers; J Flammer; A Wirz-Justice; E Savaskan
Journal:  Br J Ophthalmol       Date:  2002-09       Impact factor: 4.638

Review 2.  Melatonin membrane receptors in peripheral tissues: distribution and functions.

Authors:  Radomir M Slominski; Russel J Reiter; Natalia Schlabritz-Loutsevitch; Rennolds S Ostrom; Andrzej T Slominski
Journal:  Mol Cell Endocrinol       Date:  2012-01-08       Impact factor: 4.102

Review 3.  Hepatoprotective actions of melatonin: possible mediation by melatonin receptors.

Authors:  Alexander M Mathes
Journal:  World J Gastroenterol       Date:  2010-12-28       Impact factor: 5.742

4.  Apelin Reduces Nitric Oxide-Induced Relaxation of Cerebral Arteries by Inhibiting Activation of Large-Conductance, Calcium-Activated K Channels.

Authors:  Amreen Mughal; Chengwen Sun; Stephen T OʼRourke
Journal:  J Cardiovasc Pharmacol       Date:  2018-04       Impact factor: 3.105

Review 5.  MT1 and MT2 Melatonin Receptors: A Therapeutic Perspective.

Authors:  Jiabei Liu; Shannon J Clough; Anthony J Hutchinson; Ekue B Adamah-Biassi; Marina Popovska-Gorevski; Margarita L Dubocovich
Journal:  Annu Rev Pharmacol Toxicol       Date:  2015-10-23       Impact factor: 13.820

Review 6.  Functional MT1 and MT2 melatonin receptors in mammals.

Authors:  Margarita L Dubocovich; Magdalena Markowska
Journal:  Endocrine       Date:  2005-07       Impact factor: 3.633

Review 7.  Role of melatonin in neurodegenerative diseases.

Authors:  V Srinivasan; S R Pandi-Perumal; G Jm Maestroni; A I Esquifino; R Hardeland; D P Cardinali
Journal:  Neurotox Res       Date:  2005       Impact factor: 3.911

8.  Melatonin attenuates the sympathetic nerve responses to orthostatic stress in humans.

Authors:  Chester A Ray
Journal:  J Physiol       Date:  2003-07-17       Impact factor: 5.182

9.  Melatonin reduces noradrenaline-induced vasoconstriction in the uterine artery of pregnant hooded seals (Cystophora cristata).

Authors:  Karl-Arne Stokkan; Jo Jorem Aarseth
Journal:  Pflugers Arch       Date:  2003-11-21       Impact factor: 3.657

10.  Dose-dependent dual effect of melatonin on ototoxicity induced by amikacin in adult rats.

Authors:  Tamer Erdem; Orhan Ozturan; Mustafa Iraz; Murat Cem Miman; Ercument Olmez
Journal:  Eur Arch Otorhinolaryngol       Date:  2004-05-28       Impact factor: 2.503

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.